Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study.
Saved in:
| Title: | Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study. |
|---|---|
| Authors: | Gilmore R; Department of Gastroenterology, Mater Hospital, Brisbane, Australia.; Mater Research Institute, The University of Queensland, South Brisbane, Australia., Fernandes R; Department of Gastroenterology, Mater Hospital, Brisbane, Australia.; Mater Research Institute, The University of Queensland, South Brisbane, Australia., Hartley I; Department of Gastroenterology, St. Vincent's Hospital, Melbourne, Australia., Arzivian A; Department of Gastroenterology, Macquarie University Hospital, Sydney, Australia., Leong R; Department of Gastroenterology, Macquarie University Hospital, Sydney, Australia., Andrew B; Department of Gastroenterology, Eastern Health, Melbourne, Australia., Vasudevan A; Department of Gastroenterology, Eastern Health, Melbourne, Australia.; Monash University, Eastern Health Clinical School, Melbourne, Australia., Greeve T; Department of Gastroenterology, Monash Health, Melbourne, Australia., Moore GT; Department of Gastroenterology, Monash Health, Melbourne, Australia.; Department of Medicine, Monash University, Melbourne, Australia., Kim S; Department of Gastroenterology, Fiona Stanley Hospital, Perth, Australia., Lightowler D; Wexford Gastroenterology, Perth, Australia.; Medical School, The University of Western Australia, Perth, Australia., Singh A; Department of Gastroenterology, Fiona Stanley Hospital, Perth, Australia.; Wexford Gastroenterology, Perth, Australia., Mahy G; Department of Gastroenterology, Townsville University Hospital, Townsville, Australia., Mithanthaya A; Department of Gastroenterology, Royal Perth Hospital, Perth, Australia., Venugopaul K; Department of Gastroenterology, Royal Perth Hospital, Perth, Australia., Han S; Department of Gastroenterology, The Queen Elizabeth Hospital, Adelaide, Australia., Bryant R; Department of Gastroenterology, The Queen Elizabeth Hospital, Adelaide, Australia., West J; Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Australia., Segal J; Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia., Christensen B; Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia., Corte C; AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, Australia.; Faculty of Medicine and Health, University of Sydney, Australia., Ding N; Department of Gastroenterology, St. Vincent's Hospital, Melbourne, Australia., An YK; Department of Gastroenterology, Mater Hospital, Brisbane, Australia.; Mater Research Institute, The University of Queensland, South Brisbane, Australia., Begun J; Department of Gastroenterology, Mater Hospital, Brisbane, Australia.; Mater Research Institute, The University of Queensland, South Brisbane, Australia. |
| Source: | Intestinal research [Intest Res] 2025 Jul; Vol. 23 (3), pp. 347-357. Date of Electronic Publication: 2024 Dec 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taehan Chang Yŏn'gu Hakhoe Country of Publication: Korea (South) NLM ID: 101572802 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1598-9100 (Print) Linking ISSN: 15989100 NLM ISO Abbreviation: Intest Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1598-9100 |
|---|---|
| DOI: | 10.5217/ir.2024.00127 |
